Digital Health

News

Remepy's hybrid Parkinson's therapy poised for phase 3

Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.

News

Merck partners Remepy in PDURS-focused alliance

Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.

News

CT-155, and Boehringer Ingelheim and Click Therapeutics logos

Boehringer transfers schizophrenia DTx selling rights to Cli...

Boehringer has altered the terms of its digital therapeutic alliance with Click on schizophrenia app CT-155, taking a more strategic investor role.

News

AI predicts liver cancer risk with "high accuracy"

A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.

Digital

Why pharma’s digital health tools miss the mark

Explore the cultural, operational, and value-definition shifts required for digital health to deliver durable impact.

News

NHS hospitals 'should resist Palantir software rollout'

Hospitals in England have been told they do not have to deploy a controversial Palantir data platform by a coalition led by healthcare charity Medact.

Remepy's hybrid Parkinson's therapy poised for phase 3

Merck partners Remepy in PDURS-focused alliance

Boehringer transfers schizophrenia DTx selling rights to Cli...

AI predicts liver cancer risk with "high accuracy"

Why pharma’s digital health tools miss the mark

NHS hospitals 'should resist Palantir software rollout'

ADARx, Trex, and Retension take aim at IPOs

Discover a new era of healthcare panel engagement: Grounded ...

Digital Health

Editor's Picks